Oncopeptides presents clinical results from Phase I/II study of melflufen and dexamethasone in patients with relapsed and relapsed refractory multiple myeloma
17 June 2015 | By Victoria White
Oncopeptides has presented results from an ongoing study of melflufen with dexamethasone in patients with relapsed and relapsed refractory multiple myeloma...